Zoledronsyre udviser ingen mærkbar binding til plasmaproteiner og hæmmer ikke de humane P450- enzymer in vitro (se afsnit 5. 2), men der er ikke udført nogen formelle kliniske interaktionsstudier.
Zoledronic acid shows no appreciable binding to plasma proteins and does not inhibit human P450 enzymes in vitro (see section 5.2), but no formal clinical interaction studies have been performed.